Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
The SELECT trial specifically demonstrated that semaglutide reduces major adverse cardiovascular events by 20% in patients with established cardiovascular disease, regardless of diabetes status
Intensive blood- glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
Sexual Health Effects Explained Mounjaro (tirzepatide) is a prescription medication licensed in the UK for treating type 2 diabetes
Clinical studies have shown that many people lose an average of 10% to 15% of their starting body weight over time when semaglutide is used consistently alongside lifestyle changes
US$ 20.15
US$ 21.39
US$ 26.38
US$ 28.92
US$ 27.45
